|
|
|
|
| Advertisement |
 |
|
|
| Advertisement |
Read this Front & Center article to see how your Hub can be a Secret Weapon to improve Outcomes
 Learn more |
|
| Advertisement |
Supporting internal and external decision-making through effective MSL activities
Live Webinar: Tuesday 18th October, 11:00am EDT
 Register now |
|
|
| Global |
 |
|
CETA: Hanging in the Balance |
Can pharma help to salvage the EU's Comprehensive Economic and Trade Agreement with Canada (CETA) in the face of growing resistance? Reflector reports
... /Read more/ |
|
|
| Advertisement |
Technology can't replace people- why Patient Support Programs need a personal approach
Live Webcast: Thursday, September 29 at 8:00 EDT
 Learn more |
|
| Europe |
 |
|
UK: A Tale of Two Pricing Schemes |
The UK is moving closer to aligning its two approaches to regulating drug pricing — the voluntary PPRS and statutory price cuts — but the headaches are likely to continue, writes Leela Barham
... /Read more/ |
|
| Advertisement |
Optimizing real-world evidence programs to generate value
Tailored approaches for emerging biopharma
On Demand
 Learn more |
|
|
| Special Feature |
 |
|
Pharm Exec's Emerging Pharma Leaders 2016 |
Pharm Exec's 9th annual list of rising industry leaders illustrates how the deployment of essential human capital has changed in line with a business model that is no longer static and predictable—or complacent
... /Read more/ |
|
|
|
ADVERTISEMENT
|
| Advertisement |
Breaking the Circle of Distrust with a Radical PLC Pricing Model
On Demand
 Learn more |
|
|
| Industry update |
| //GSK announced that Emma Walmsley will take over from CEO Andrew Witty when he retires in March 2017.//Sanofi appointed Dr. Frank Nestle as North American Chief Scientific Officer. //Insys Therapeutics, Inc. (Phoenix, AZ) announced that it has initiated a search for a candidate to succeed Dr. John N. Kapoor as President and CEO.//Randy J. Maddux joined Aptevo Therapeutics Inc. (Seattle, WA) as Senior Vice President, Operations.// |
| Advertisement |
Best Practices for Integrating Biomarkers
across the Drug Development Continuum
On Demand
 Learn more |
|
|
|
|
| |
|
